GGrantIndex
← Search

CHARACTERIZATION OF DIABETES ASSOCIATED WITH PROTEASE INHIBITOR TREATMENT

$0M01FY2000RRNIH

University Of Rochester, Rochester NY

Investigators

Linked publications & trials

Abstract

To evaluate the safety & immunogenicity of live recombinant canarypox ALVAC-HIV VCP205 vector into which HIV genes encoding the entire gag protein and a portion of the polysequence sufficent to evoke protease activity. The experimental vaccine is to be given to healthy HIV-1 uninfected volunteers by alternate routes of delivery to assess the development of mucosal immunity.

View original record on NIH RePORTER →